Literature DB >> 10894808

Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection.

A C Carr1, M R McCall, B Frei.   

Abstract

Oxidative modification of low density lipoprotein (LDL) appears to play an important role in atherogenesis. Although the precise mechanisms of LDL oxidation in vivo are unknown, several lines of evidence implicate myeloperoxidase and reactive nitrogen species, in addition to ceruloplasmin and 15-lipoxygenase. Myeloperoxidase generates a number of reactive species, including hypochlorous acid, chloramines, tyrosyl radicals, and nitrogen dioxide. These reactive species oxidize the protein, lipid, and antioxidant components of LDL. Modification of apolipoprotein B results in enhanced uptake of LDL by macrophages with subsequent formation of lipid-laden foam cells. Nitric oxide synthases produce nitric oxide and, under certain conditions, superoxide radicals. Numerous other sources of superoxide radicals have been identified in the arterial wall, including NAD(P)H oxidases and xanthine oxidase. Nitric oxide and superoxide readily combine to form peroxynitrite, a reactive nitrogen species capable of modifying LDL. In this review, we examine the reaction pathways involved in LDL oxidation by myeloperoxidase and reactive nitrogen species and the potential protective effects of the antioxidant vitamins C and E.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894808     DOI: 10.1161/01.atv.20.7.1716

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  87 in total

Review 1.  Myeloperoxidase production by macrophage and risk of atherosclerosis.

Authors:  Mahir Karakas; Wolfgang Koenig
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 2.  Effects of antioxidants against atherosclerosis.

Authors:  Etsuo Niki; Noriko Noguchi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

3.  Arjunolic acid ameliorates reactive oxygen species via inhibition of p47(phox)-serine phosphorylation and mitochondrial dysfunction.

Authors:  Sumitra Miriyala; Mini Chandra; Benjamin Maxey; Alicia Day; Daret K St Clair; Manikandan Panchatcharam
Journal:  Int J Biochem Cell Biol       Date:  2015-08-28       Impact factor: 5.085

Review 4.  The role of myeloperoxidase in HDL oxidation and atherogenesis.

Authors:  Jay W Heinecke
Journal:  Curr Atheroscler Rep       Date:  2007-10       Impact factor: 5.113

Review 5.  Oxidative stress--implications, source and its prevention.

Authors:  Rajbir Kaur; Jasmit Kaur; Jyoti Mahajan; Rakesh Kumar; Saroj Arora
Journal:  Environ Sci Pollut Res Int       Date:  2013-10-30       Impact factor: 4.223

Review 6.  Exploring the biology of lipid peroxidation-derived protein carbonylation.

Authors:  Kristofer S Fritz; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2011-08-18       Impact factor: 3.739

7.  Hydrocortisone and Ascorbic Acid Synergistically Prevent and Repair Lipopolysaccharide-Induced Pulmonary Endothelial Barrier Dysfunction.

Authors:  Nektarios Barabutis; Vikramjit Khangoora; Paul E Marik; John D Catravas
Journal:  Chest       Date:  2017-07-21       Impact factor: 9.410

Review 8.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

9.  Participation of ATP7A in macrophage mediated oxidation of LDL.

Authors:  Zhenyu Qin; Eddy S Konaniah; Bonnie Neltner; Raphael A Nemenoff; David Y Hui; Neal L Weintraub
Journal:  J Lipid Res       Date:  2009-11-23       Impact factor: 5.922

10.  Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders.

Authors:  Genaro G Ortiz; Gloria A Benítez-King; Sergio A Rosales-Corral; Fermín P Pacheco-Moisés; Irma E Velázquez-Brizuela
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.